Related Experiment Video
Updated: May 22, 2025
10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
10.5K
Strategic re-engineering of antibiotics
Joshua A Homer1, Robert M Johnson1, Rebecca A Koelln1
1Cancer Center, Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
Nature Reviews Bioengineering
|May 19, 2025
Summary
Reengineering existing antibiotics offers a promising strategy against multidrug-resistant bacteria, a growing global health threat. This approach enhances antibiotic effectiveness and addresses critical challenges in combating resistant infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Multidrug-resistant bacteria (MDRB) pose a significant global health crisis, exacerbated by antibiotic overuse and a decline in new antibiotic development.
- MDRB infections complicate medical treatments, including surgeries and cancer therapies, leading to increased morbidity, mortality, and healthcare expenses.
- The diminishing efficacy of current antibiotics necessitates innovative strategies to combat resistant bacterial strains.
Purpose of the Study:
- To review and discuss reengineering approaches for existing antibiotics to combat multidrug-resistant bacterial infections.
- To explore methods for enhancing antibiotic activity against resistant bacteria.
- To examine the challenges associated with antibiotic reengineering and its translation into clinical practice.
Main Methods:
- Structural modifications of existing antibiotics to restore or enhance activity.
- Engineering of polyvalent drugs designed to target multiple resistance mechanisms.
- Development of combination therapies to overcome bacterial resistance.
Main Results:
- Reengineering strategies can significantly increase antibiotic efficacy against drug-resistant bacteria.
- Structural modifications and novel drug designs can overcome key bacterial resistance mechanisms.
- Combination therapies show potential in restoring the effectiveness of previously ineffective antibiotics.
Conclusions:
- Antibiotic reengineering presents a viable strategy to combat the growing threat of multidrug-resistant bacteria.
- Overcoming resistance mechanisms through innovative drug design and combination therapies is crucial.
- Addressing regulatory hurdles and promoting antibiotic stewardship are essential for the successful implementation of reengineered antibiotics.
Related Concept Videos
00:57Antibiotic Selection
52.1K
Overview
52.1K
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:28Structure-Activity Relationships and Drug Design
474
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
474
01:33Bacterial Transformation
55.0K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.0K